Response to: Correspondence on "g-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al

Paula Martinez Sanz; Dieke J. Van Rees; Hanke L. Matlung; Godelieve A.M. Tytgat; Katka Franke

doi:10.1136/jitc-2021-003983

Response to: Correspondence on "g-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al

Paula Martinez Sanz, Dieke J. Van Rees, Hanke L. Matlung, Godelieve A.M. Tytgat, Katka Franke

Group Tytgat

Onderzoeksoutput: Bijdrage aan tijdschrift › Brief › peer review

Originele taal-2	Engels
Artikelnummer	e003983
Tijdschrift	Journal for ImmunoTherapy of Cancer
Volume	9
Nummer van het tijdschrift	12
DOI's	https://doi.org/10.1136/jitc-2021-003983
Status	Gepubliceerd - 1 dec. 2021

Toegang tot document

10.1136/jitc-2021-003983

Citeer dit

@article{303b02ae386a496ba5d37e6d47a53c1c,

title = "Response to: Correspondence on {"}g-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment{"} by Mora et al",

keywords = "cytokines, immunotherapy, neuroblastoma",

author = "\{Martinez Sanz\}, Paula and \{Van Rees\}, \{Dieke J.\} and Matlung, \{Hanke L.\} and Tytgat, \{Godelieve A.M.\} and Katka Franke",

year = "2021",

month = dec,

day = "1",

doi = "10.1136/jitc-2021-003983",

language = "English",

volume = "9",

journal = "Journal for ImmunoTherapy of Cancer",

issn = "2051-1426",

publisher = "BMJ Publishing Group",

number = "12",

}

Response to: Correspondence on "g-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al. / Martinez Sanz, Paula; Van Rees, Dieke J.; Matlung, Hanke L. et al.
In: Journal for ImmunoTherapy of Cancer, Vol. 9, Nr. 12, e003983, 01.12.2021.

Onderzoeksoutput: Bijdrage aan tijdschrift › Brief › peer review

TY - JOUR

T1 - Response to

T2 - Correspondence on "g-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al

AU - Martinez Sanz, Paula

AU - Van Rees, Dieke J.

AU - Matlung, Hanke L.

AU - Tytgat, Godelieve A.M.

AU - Franke, Katka

PY - 2021/12/1

Y1 - 2021/12/1

KW - cytokines

KW - immunotherapy

KW - neuroblastoma

UR - https://www.scopus.com/pages/publications/85122483698

U2 - 10.1136/jitc-2021-003983

DO - 10.1136/jitc-2021-003983

M3 - Letter

C2 - 34893526

AN - SCOPUS:85122483698

SN - 2051-1426

VL - 9

JO - Journal for ImmunoTherapy of Cancer

JF - Journal for ImmunoTherapy of Cancer

IS - 12

M1 - e003983

ER -